Encainide [French]
Encainide [French] Brand names, Encainide [French] Analogs
Encainide [French] Brand Names Mixture
- No information avaliable
Encainide [French] Chemical_Formula
C22H28N2O2
Encainide [French] RX_link
No information avaliable
Encainide [French] fda sheet
Encainide [French] msds (material safety sheet)
Encainide [French] Synthesis Reference
No information avaliable
Encainide [French] Molecular Weight
352.47 g/mol
Encainide [French] Melting Point
No information avaliable
Encainide [French] H2O Solubility
No information avaliable
Encainide [French] State
Solid
Encainide [French] LogP
4.427
Encainide [French] Dosage Forms
No information avaliable
Encainide [French] Indication
For management of irregular heartbeats to a normal rhythm.
Encainide [French] Pharmacology
Used to treat irregular heartbeats, encainide decreases excitability, conduction velocity, and automaticity as a result of slowed atrial, atrioventricular (AV) nodal, His-Purkinje, and intraventricular conduction. It causes a slight but significant prolongation of refractory periods in these tissues. The greatest effect is on the His-Purkinje system. Encainide decreases the rate of rise of the action potential without markedly affecting its duration.
Encainide [French] Absorption
No information avaliable
Encainide [French] side effects and Toxicity
No information avaliable
Encainide [French] Patient Information
No information avaliable
Encainide [French] Organisms Affected
Humans and other mammals
![Encainide_[French]](/images/rx/APRD00613.gif)
